Vinva Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-53,982
Closed -$4.9M 503
2025
Q4
$4.9M Sell
53,982
-56,777
-51% -$5.38M 0.06% 209
2025
Q3
$10.9M Buy
110,759
+98,245
+785% +$9.74M 0.21% 122
2025
Q2
$1.14M Buy
12,514
+3,759
+43% +$363K 0.03% 292
2025
Q1
$983K Sell
8,755
-1,302
-13% -$139K 0.04% 281
2024
Q4
$1.06M Buy
+10,057
New +$1.08M 0.04% 282
2024
Q3
Sell
-8,423
Closed -$913K 462
2024
Q2
$913K Buy
8,423
+363
+5% +$42.8K 0.05% 305
2024
Q1
$1.06M Sell
8,060
-4,816
-37% -$602K 0.06% 284
2023
Q4
$1.57M Buy
12,876
+6,059
+89% +$676K 0.11% 208
2023
Q3
$767K Sell
6,817
-1,164
-15% -$148K 0.07% 253
2023
Q2
$1.16M Buy
7,981
+533
+7% +$72.4K 0.1% 221
2023
Q1
$944K Buy
+7,448
New +$935K 0.08% 253

Other funds holding ZBH

Vinva Investment Management's ZBH Position: Q1 2026 in Review

Vinva Investment Management sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 53,982 shares — an estimated $4.9M sold.

Vinva Investment Management first reported a position in ZBH in Q1 2023 and held it in 11 quarters. The position peaked at $10.9M in Q3 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Vinva Investment Management reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Vinva Investment Management sold 53,982 Zimmer Biomet shares in Q1 2026, an estimated $4.9M.
  • Vinva Investment Management first reported a position in Zimmer Biomet in Q1 2023 and held it in 11 quarters.
  • Vinva Investment Management's Zimmer Biomet position peaked at $10.9M in Q3 2025.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.